Features | Partner Sites | Information | LinkXpress
Sign In
SIEMENS DIAGNOSTICS

Fungi Identified in Asthma Patients’ Lungs

By Labmedica International staff writers
Posted on 05 Mar 2013
Image: The fungi Malassezia pachydermatis (Photo courtesy of the Pathogenic Fungi Database).
Image: The fungi Malassezia pachydermatis (Photo courtesy of the Pathogenic Fungi Database).
Hundreds of tiny fungal particles have been found in the lungs of asthma sufferers and could offer new clues in the development of new treatments.

There is increasing evidence that microorganisms are present even in healthy lungs and this finding raises the possibility of a potential overlap between pathogenic and commensal microbiota in the respiratory tract.

A team of scientists at Cardiff University (UK) used molecular techniques to identify eukaryote species that were present in induced sputum samples taken from 30 asthma patients and 13 nonatopic controls. Patients had a mean age of 41.6 years and control participants had a mean age of 35.7 years. The patient group was 40% male and the control group was 46% male.

DNA was extracted from the sputum samples and was amplified using a polymerase chain reaction (PCR) protocol for the partial 18S ribosomal ribonucleic acid (rRNA) gene using primer pairs. The two pooled extract amplicons, from asthma patients and from controls, were sequenced using a 454 pyrosequencer by Research and Testing Inc. (Lubbock, TX, USA). A total of 136 fungal species were identified in the induced sputum samples, with 90 species more common in asthma patients and 46 species more common in control subjects, based on the percent of total DNA reads. The fungi Malassezia pachydermatis, was found in patients with asthma and not the control group. Two of the fungi most commonly found in the sputum of asthma patients were Termitomyces clypeatus and Psathyrella candolleana, both represent members of the basidiomycete family.

Hugo Cornelis van Woerden, MBChB, MPH, the senior author said, “Historically, the lungs were thought to be sterile. Our analysis found that there are large numbers of fungi present in healthy human lungs. The study also demonstrates that asthma patients have a large number of fungi in their lungs and that the species of fungi are quite different to those present in the lungs of healthy individuals. In the future it is conceivable that individual patients may have their sputum tested for fungi and their treatment adjusted accordingly.” The study was published on February 5, 2013, in the Biomed Central’s journal BMC Infectious Diseases.

Related Links:

Cardiff University
Research and Testing Inc.



comments powered by Disqus

Channels

Clinical Chemistry

view channel
Image: The URiSCAN Super Plus reflectance meter (Photo courtesy of YD Diagnostics).

Semiquantitative Urine Dipstick Evaluated for Microalbuminuria Screening

The urine microalbumin test is used as a screening test for the diagnosis of renal complications in diseases, such as diabetic nephropathy, cardiovascular disease, and hypertension. A urine dipstick... Read more

Pathology

view channel
Image: The BD Viper LT System for fully automated, integrated molecular testing on a table top analyzer (Photo courtesy of BD Diagnostics).

Modern Methods Accurately Detects Cervical Cancer

The newer Papanicolaou test (Pap tests) and human papilloma virus (HPV) screening more accurately identify precancerous cellular changes that potentially develop into cervical cancer. Compared to a... Read more

Lab Tech.

view channel
Image: RNAscope detects TP63 mRNA expression in human prostate tissue (Photo courtesy of Advanced Cell Diagnostics).

RNA Biomarker Assay Now Manufactured According to Strict ISO Regulatory Criteria

A line of diagnostic kits that measures RNA biomarkers with single-molecule sensitivity is now being manufactured under the stringent requirements of ISO 13485:2003 certification. Advanced Cell Diagnostics, Inc.... Read more

Industry News

view channel

Social Diagnostics Start-Up to Provide Simple, Affordable Tests Worldwide

The Royal Tropical Institute (KIT; Amsterdam, Netherlands) is establishing a nonprofit, social diagnostics company that develops and markets tests for the diagnosis of poverty-related diseases. Infectious diseases have a global impact; they take no account of national borders and influence the stability of societies... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.